Table 3.
Estimate of serious fungal diseases in Uganda.
| Serious fungal diseases | Measure | No underlying disease | HIV | Respiratory disease | Hematology/oncology | Critical care + surgery | Rate/100,000 | Total |
|---|---|---|---|---|---|---|---|---|
| Candidiasis | ||||||||
| Recurrent Candida vaginitis (⩾4×/year) | I | 656,340 | 2870 | 656,340 | ||||
| Oral candidiasis | I | 29,057 | 63.5 | 29,057 | ||||
| Esophageal candidiasis | I | 74,686 | 163.3 | 74,686 | ||||
| Candidemia | I | 1601 | 686 | 5.0 | 2287 | |||
| Candida peritonitis | I | 343 | 0.8 | 343 | ||||
| Cryptococcosis | ||||||||
| Cryptococcal meningitis | I | 5553 | 12.1 | 5553 | ||||
| Pneumocystosis | ||||||||
| Pneumocystis pneumonia in adults | I | 4604 | 10.1 | 4604 | ||||
| PCP in children | I | 2100 | 4.6 | 2100 | ||||
| Aspergillosis | ||||||||
| Invasive aspergillosis | I | 680 | 2570 | 357 | 7.9 | 3607 | ||
| CPA | I | 26,241 | 57.4 | 26,241 | ||||
| CPA | P | 63,574 | 137.1 | 63,574 | ||||
| ABPA in asthma | P | 75,931 | 166.0 | 75,931 | ||||
| SAFS | P | 100,228 | 219.1 | 100,228 | ||||
| Superficial and implantation mycoses | ||||||||
| Tinea capitis | P | 3,047,989 | 6664 | 3,047,989 | ||||
| Fungal keratitis | I | 6084 | 13.3 | 6084 | ||||
| Mycetoma | I | 79 | 0.3 | 79 | ||||
| Other mycoses | ||||||||
| Histoplasmosis | I | 646 | 1.4 | 646 | ||||
| Mucormycosis | I | 9 | 0.02 | 9 | ||||
| Total | 4,099,357 |
ABPA, allergic bronchopulmonary aspergillosis; CPA, chronic pulmonary aspergillosis; I, annual incidence; PCP, Pneumocystis jirovecii pneumonia; P, prevalence; SAFS, severe asthma with fungal sensitization.